SG11201600133TA - Method for isolating stromal vascular fraction - Google Patents

Method for isolating stromal vascular fraction

Info

Publication number
SG11201600133TA
SG11201600133TA SG11201600133TA SG11201600133TA SG11201600133TA SG 11201600133T A SG11201600133T A SG 11201600133TA SG 11201600133T A SG11201600133T A SG 11201600133TA SG 11201600133T A SG11201600133T A SG 11201600133TA SG 11201600133T A SG11201600133T A SG 11201600133TA
Authority
SG
Singapore
Prior art keywords
stromal vascular
vascular fraction
isolating stromal
isolating
fraction
Prior art date
Application number
SG11201600133TA
Inventor
Shigeki Sugii
Wee Kiat Ong
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG11201600133TA priority Critical patent/SG11201600133TA/en
Publication of SG11201600133TA publication Critical patent/SG11201600133TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2527/00—Culture process characterised by the use of mechanical forces, e.g. strain, vibration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201600133TA 2013-07-10 2014-07-10 Method for isolating stromal vascular fraction SG11201600133TA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG11201600133TA SG11201600133TA (en) 2013-07-10 2014-07-10 Method for isolating stromal vascular fraction

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG2013053095 2013-07-10
PCT/SG2014/000327 WO2015005871A1 (en) 2013-07-10 2014-07-10 Method for isolating stromal vascular fraction
SG11201600133TA SG11201600133TA (en) 2013-07-10 2014-07-10 Method for isolating stromal vascular fraction

Publications (1)

Publication Number Publication Date
SG11201600133TA true SG11201600133TA (en) 2016-02-26

Family

ID=52280391

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201600133TA SG11201600133TA (en) 2013-07-10 2014-07-10 Method for isolating stromal vascular fraction

Country Status (5)

Country Link
US (1) US20160143955A1 (en)
EP (1) EP3019599B1 (en)
CN (1) CN105531366A (en)
SG (1) SG11201600133TA (en)
WO (1) WO2015005871A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016199149A1 (en) 2015-06-10 2016-12-15 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Mechanical apparatus and method for isolating stromal vascular fraction
WO2017180076A1 (en) * 2016-04-13 2017-10-19 Kemal Tunc Tiryaki Obtaining stromal vascular cells from human adipose tissue by mechanical separation
WO2018148669A2 (en) * 2017-02-10 2018-08-16 Obatala Sciences, Inc. Biological scaffolds, products containing biological scaffolds and methods of using the same
TWI616526B (en) * 2017-05-15 2018-03-01 Cell separation and purification device
CN109876189B (en) * 2018-05-28 2022-02-18 聂云飞 Method for efficiently preparing fat source biological material by utilizing ultrasonic waves
CN109609455A (en) * 2018-12-28 2019-04-12 诺未科技（北京）有限公司 The cultivating system of amplifying candidate stem cell, method and application thereof
US20220288128A1 (en) * 2019-07-16 2022-09-15 Akan Biosciences Llc Mesenchymal stem cell compositions
TR201913977A1 (en) * 2019-09-16 2021-04-21 T Biyoteknoloji Laboratuvar Estetik Medikal Kozmetik San Tic Ltd Sti A METHOD TO OBTAIN A STROMAL VASCULAR FRACTION
US20220025316A1 (en) 2020-07-22 2022-01-27 Prim Sigma Technologies, Inc. Trituration devices for tissue disaggregation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145002A0 (en) * 1999-03-10 2002-06-30 Univ Pittsburgh Adipose-derived stem cells and lattices
US20030082152A1 (en) * 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
US20030054331A1 (en) * 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
WO2011032025A2 (en) 2009-09-10 2011-03-17 The Salk Institute For Biological Studies Adipose-derived induced pluripotent stem cells
CN102485885A (en) * 2011-06-09 2012-06-06 臻景生物技术（上海）有限公司 Separating method and application of fat stem cells
US9512405B2 (en) * 2011-12-14 2016-12-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Non-enzymatic method for isolating human adipose-derived stromal stem cells
WO2014036094A1 (en) * 2012-08-28 2014-03-06 Intellicell Biosciences Inc. Isolation of stromal vascular fraction from adipose tissue obtained using homogenization with beads

Also Published As

Publication number Publication date
EP3019599A4 (en) 2017-03-22
EP3019599B1 (en) 2018-06-13
US20160143955A1 (en) 2016-05-26
WO2015005871A1 (en) 2015-01-15
EP3019599A1 (en) 2016-05-18
CN105531366A (en) 2016-04-27

Similar Documents

Publication Publication Date Title
IL267526B (en) Methods for isolating microvesicles
LT3076949T (en) Method for isolating cancer cell-derived exoxomes
SG11201600133TA (en) Method for isolating stromal vascular fraction
GB201309057D0 (en) Method
ZA201600018B (en) Method for improving adherence
GB201315777D0 (en) Novel method
GB201303521D0 (en) Process operations for biomass fractionation
GB201309928D0 (en) Method
GB201301857D0 (en) Method
GB201309654D0 (en) Method
GB201301233D0 (en) Method
GB201300409D0 (en) Method
GB201311385D0 (en) Method
GB201305714D0 (en) Method
GB201310151D0 (en) Novel method
GB201301094D0 (en) Method
HRP20181451T1 (en) Factor h for transplantation
HK1222185A1 (en) Method for isolating caspofungin
GB201311389D0 (en) Method
PL126622U1 (en) Isolating inset for rails
GB201301977D0 (en) New method for safening
GB201311377D0 (en) Method
GB201311391D0 (en) Method
GB201311392D0 (en) Method
GB201311394D0 (en) Method